Unnamed: 0,title,date,stock,sentiment
818845.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,MEIP,negative
818846.0,Stocks That Hit 52-Week Highs On Monday,2020-06-01 10:41:00-04:00,MEIP,neutral
818847.0,Why MEI Pharma's Stock Is Trading Higher Today,2020-05-29 10:59:00-04:00,MEIP,neutral
818848.0,Stocks That Hit 52-Week Highs On Friday,2020-05-29 10:36:00-04:00,MEIP,neutral
818849.0,"Benzinga's Top Upgrades, Downgrades For May 29, 2020",2020-05-29 10:01:00-04:00,MEIP,positive
818850.0,MEI Pharma shares are trading higher after SunTrust Robinson Humphrey initiated coverage on the stock with a Buy rating and a price target of $16 per share.,2020-05-29 09:07:00-04:00,MEIP,positive
818851.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-29 07:39:00-04:00,MEIP,neutral
818852.0,"SunTrust Robinson Humphrey Initiates Coverage On MEI Pharma with Buy Rating, Announces Price Target of $16",2020-05-29 07:22:00-04:00,MEIP,neutral
818853.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,MEIP,positive
818854.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,MEIP,positive
818855.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-26 10:32:00-04:00,MEIP,neutral
818856.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,MEIP,neutral
818857.0,"MEI Pharma, Kyowa Kirin To Highlight Phase 1b Study Of ME-401 At European Hematology Association Congress",2020-05-14 10:35:00-04:00,MEIP,positive
818858.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,MEIP,positive
818859.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-14 07:40:00-04:00,MEIP,neutral
818860.0,32 Stocks Moving in Thursday's Pre-Market Session,2020-05-14 07:15:00-04:00,MEIP,neutral
818861.0,"MEI Pharma, Kyowa Kirin Highlight Updated Clinical Data From Phase 1b Study Of ME-401 On Intermittent Schedule in Patients with Follicular Lymphoma and Other B-cell Malignancies For ASCO: 83% Overall Response Rate",2020-05-13 17:13:00-04:00,MEIP,positive
818862.0,MEI Pharma Files For A Mixed Shelf Offering Of Up To $200M,2020-05-07 08:36:00-04:00,MEIP,neutral
818863.0,MEI Pharma Q3 EPS $(0.040) Up From $(0.170) YoY,2020-05-07 07:42:00-04:00,MEIP,neutral
818864.0,50 Stocks Moving In Wednesday's Mid-Day Session,2020-04-15 12:35:00-04:00,MEIP,neutral
818865.0,Shares of several healthcare companies are trading lower amid overall market weakness caused by the coronavirus which has decreased consumer spending and economic activity.,2020-04-15 10:05:00-04:00,MEIP,negative
818866.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,MEIP,neutral
818867.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-04-15 07:04:00-04:00,MEIP,neutral
818868.0,UPDATE: Wells Fargo Notes MEI Pharma's 'Extended Cash Runway' Another Reason Firm Sees 'Significant Upside Opportunity',2020-04-14 10:35:00-04:00,MEIP,positive
818869.0,UPDATE: Wells Fargo Reiterates Overweight Rating On MEI Pharma Following News Of An Expanded Partnership With Kyowa Kirin For Development Of ME-401,2020-04-14 10:35:00-04:00,MEIP,negative
818870.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-14 10:31:00-04:00,MEIP,neutral
818871.0,MEI Pharma Shares Tick Higher To $3 Level On Spike In Volume; Traders Circulate Word Wells Fargo Raises Price Target To Street High $13,2020-04-14 10:30:00-04:00,MEIP,positive
818872.0,MEI Pharma shares are trading higher after the company announced a global license development and commercialization agreement with Kyowa Kirin for ME-401. The company will receive $100M in a upfront cash payment and is eligible for up to $582.5M in milestones.,2020-04-14 09:26:00-04:00,MEIP,positive
818873.0,17 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-04-14 07:57:00-04:00,MEIP,neutral
818874.0,"MEI Pharma And Kyowa Kirin Announce Global License, Development And Commercialization Agreement For ME-401; MEI To Receive $100M Upfront Cash Payment And Is Eligible For Up To $582.5MIn Milestones",2020-04-14 07:11:00-04:00,MEIP,positive
818875.0,MEI Pharma Announces Fast Track Designation Granted By FDA For ME-401 For Treatment Of Adult Patients With Relapsed Or Refractory Follicular Lymphoma,2020-03-31 08:21:00-04:00,MEIP,positive
818876.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,MEIP,negative
818877.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-19 10:49:00-04:00,MEIP,negative
818878.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,MEIP,neutral
818879.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,MEIP,negative
818880.0,"MEI Pharma Q2 EPS $(0.26) Down From $(0.15) YoY, Sales $1.008M Down From $2.048M YoY",2020-02-06 16:26:00-05:00,MEIP,neutral
818881.0,70 Biggest Movers From Yesterday,2020-01-31 05:24:00-05:00,MEIP,neutral
818882.0,15 Stocks Moving in Tuesday's Pre-Market Session,2019-12-31 07:31:00-05:00,MEIP,neutral
818883.0,3 Stocks Moving In Monday's After-Hours Session,2019-12-30 18:03:00-05:00,MEIP,neutral
818884.0,New Enterprise Associates 16 Reports 9.8% Active Stake In MEI Pharma,2019-12-30 17:20:00-05:00,MEIP,positive
818885.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,MEIP,neutral
818886.0,MEI Pharma Option Alert: Mar 20 $2.5 Calls Sweep (2) near the Ask: 1221 @ $0.201 vs 8213 OI; Earnings 2/6 Before Open [est] Ref=$2.27,2019-12-27 09:36:00-05:00,MEIP,positive
818887.0,"MEI Pharma Inc CEO Gold Buys 18,750 Shares @$1.60",2019-12-20 12:56:00-05:00,MEIP,positive
818888.0,68 Biggest Movers From Yesterday,2019-12-18 04:56:00-05:00,MEIP,neutral
818889.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-12-17 12:01:00-05:00,MEIP,neutral
818890.0,Mid-Morning Market Update: Markets Edge Higher; Jabil Beats Q1 Expectations,2019-12-17 10:24:00-05:00,MEIP,neutral
818891.0,MEI Pharma Prices 28.125M Share Common Stock Offering At $1.60/Share,2019-12-17 08:17:00-05:00,MEIP,positive
818892.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-17 07:57:00-05:00,MEIP,neutral
818893.0,MEI Pharma shares are trading lower after the company announced a common stock offering of no disclosed size.,2019-12-17 07:32:00-05:00,MEIP,negative
818894.0,30 Stocks Moving in Tuesday's Pre-Market Session,2019-12-17 07:25:00-05:00,MEIP,neutral
818895.0,74 Biggest Movers From Yesterday,2019-12-17 05:35:00-05:00,MEIP,neutral
818896.0,MEI Pharma shares are trading lower after the company announced a common stock offering of no disclosed size.,2019-12-16 16:06:00-05:00,MEIP,negative
818897.0,MEI Pharma Announces Common Stock Offering; Size Not Disclosed,2019-12-16 16:01:00-05:00,MEIP,neutral
818898.0,"MEI Pharma Q1 EPS $(0.04) Up From $(0.14) YoY, Sales $1.157M Up From $488K YoY",2019-11-07 16:42:00-05:00,MEIP,neutral
818899.0,16 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-04 08:21:00-04:00,MEIP,neutral
818900.0,MEI Pharma shares are trading higher after the company announced it updated its clinical data from ME-401 phase 1B study.,2019-10-04 08:09:00-04:00,MEIP,positive
818901.0,22 Stocks Moving in Friday's Pre-Market Session,2019-10-04 07:41:00-04:00,MEIP,neutral
818902.0,"The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering",2019-10-04 07:32:00-04:00,MEIP,negative
818903.0,MEI Pharma shares are trading higher after the company announced it updated its clinical data from ME-401 phase 1B study.,2019-10-03 16:07:00-04:00,MEIP,positive
818904.0,MEI Pharma Announces Updated Clinical Data From ME-401 Phase 1B Study In Patients With Indolent B-Cell Malignancies,2019-10-03 16:03:00-04:00,MEIP,neutral
818905.0,MEI Pharma shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2019-08-28 16:42:00-04:00,MEIP,positive
818906.0,"MEI Pharma Q4 EPS $(0.15) Beats $(0.2) Estimate, Sales $1.13M Beat $830K Estimate",2019-08-28 16:40:00-04:00,MEIP,neutral
818907.0,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved",2019-08-28 07:31:00-04:00,MEIP,positive
818908.0,"Earnings Scheduled For August 28, 2019",2019-08-28 04:09:00-04:00,MEIP,neutral
818909.0,The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend,2019-08-25 15:06:00-04:00,MEIP,neutral
818910.0,"The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission",2019-08-16 07:33:00-04:00,MEIP,negative
818911.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,MEIP,negative
818912.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,MEIP,neutral
818913.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Fri., July 26, 2019",2019-07-26 14:21:00-04:00,MEIP,positive
818914.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,MEIP,neutral
818915.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,MEIP,neutral
818916.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,MEIP,negative
818917.0,MEI Pharma Presents Updated Clinical Data from the ME-401 Phase 1b study in Patients with Indolent B-cell Malignancies at #ICML2019,2019-06-23 07:48:00-04:00,MEIP,neutral
818918.0,"MEI Pharma Highlights Updated Data From ME-401 Monotherapy, In Combo With Rituximab Phase 1b Study In Patients With Follicular Lymphoma At ASCO",2019-06-03 09:02:00-04:00,MEIP,neutral
818919.0,MEI Pharma Says Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer Patients Showing Significant Biologic Activity at #ASCO2019,2019-06-01 12:17:00-04:00,MEIP,negative
818920.0,The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace,2019-06-01 11:37:00-04:00,MEIP,neutral
818921.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2019-05-26 17:03:00-04:00,MEIP,neutral
818922.0,"MEI Pharma Q3 EPS $(0.24) Misses $(0.17) Estimate, Sales $1.25M Beat $690K Estimate",2019-05-09 16:42:00-04:00,MEIP,negative
818923.0,MEI Pharma To Present At 29th Annual Oppenheimer Healthcare Conference,2019-03-12 08:10:00-04:00,MEIP,neutral
818924.0,BTIG Research Initiates Coverage On MEI Pharma with Buy Rating,2019-02-13 07:09:00-05:00,MEIP,neutral
818925.0,"The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs",2019-02-08 09:17:00-05:00,MEIP,negative
818926.0,"MEI Pharma Q2 EPS $(0.15) Misses $(0.12) Estimate, Sales $2.05M Miss $2.08M Estimate",2019-02-07 16:58:00-05:00,MEIP,negative
818927.0,48 Biggest Movers From Friday,2018-12-31 05:18:00-05:00,MEIP,neutral
818928.0,"Benzinga's Top Upgrades, Downgrades For December 20, 2018",2018-12-20 09:10:00-05:00,MEIP,positive
818929.0,"H.C. Wainwright Initiates Coverage On MEI Pharma with Buy Rating, Announces $10 Price Target",2018-12-20 07:52:00-05:00,MEIP,neutral
818930.0,MEI Pharma Announces Presentation Of Phase 2 Data Evaluating Combination Of Pracinostat And Azacitidine In Patients With Myelodysplastic Syndrome At 2018 American Society Of Hematology Annual Meeting,2018-12-03 13:44:00-05:00,MEIP,neutral
818931.0,MEI Pharma Presents Supportive Clinical Data from Ongoing Phase 1b Study of ME-401 in Patients with Indolent B-Cell Malignancies at ASH 2018,2018-12-02 19:56:00-05:00,MEIP,positive
818932.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,MEIP,neutral
818933.0,"MEI Pharma Q1 EPS $(0.21) Misses $(0.12) Estimate, Sales $488K Beat $370K Estimate",2018-11-08 16:21:00-05:00,MEIP,negative
818934.0,"MEI Pharma to License ME-401 to Kyowa Hakko Kirin for Japanese Licensing, MEI Pharma to Recieve $10M Upfront and Up to $87.5M of Milestone Payments",2018-11-05 08:11:00-05:00,MEIP,neutral
818935.0,"UPDATE: MEI Pharma To Receive $10M Upfront Payment, Eligible To Receive Added Development, Commercialization Milestones Totaling Up To $87.5M",2018-11-05 08:04:00-05:00,MEIP,neutral
818936.0,"MEI Pharma, Kyowa Hakko Kirin Report License Deal To Develop, Commercialize ME-401 In Japan",2018-11-05 08:04:00-05:00,MEIP,neutral
818937.0,"MEI Pharma, BeiGene Report Collaboration To Evaluate ME-401 In Combo With Zanubrutinib In Patients With B-Cell Malignancies",2018-10-11 06:05:00-04:00,MEIP,neutral
818938.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",2018-08-31 08:29:00-04:00,MEIP,positive
818939.0,26 Stocks Moving In Friday's Pre-Market Session,2018-08-31 08:08:00-04:00,MEIP,neutral
818940.0,"MEI Pharma Reports Q4 EPS (0.36) Misses $(0.20) Est., Sales $548K Beats $450K Est.",2018-08-30 16:31:00-04:00,MEIP,negative
818941.0,"MEI Pharma Reports FY18 EPS $(0.97) vs $0.07 In Prior Year, Sales $1.6M",2018-08-30 16:17:00-04:00,MEIP,neutral
818942.0,"The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",2018-08-30 08:02:00-04:00,MEIP,neutral
818943.0,50 Biggest Movers From Yesterday,2018-08-23 05:10:00-04:00,MEIP,neutral
818944.0,"Stifel Doubles Down On MEI Pharma, Considers ME-401 'Best-In-Class'",2018-07-27 10:29:00-04:00,MEIP,neutral
818945.0,"Benzinga's Top Upgrades, Downgrades For July 27, 2018",2018-07-27 09:17:00-04:00,MEIP,positive
818946.0,"Stifel Nicolaus Upgrades MEI Pharma to Buy, Raises Price Target to $7",2018-07-27 07:15:00-04:00,MEIP,neutral
818947.0,MEI Pharma Promotes David M. Urso to COO,2018-07-16 08:10:00-04:00,MEIP,positive
818948.0,MEI Pharma Shares Rise 12.2% Premarket After SunTrust Robinson Humphrey Initiated Coverage With A Buy Rating And $12 Price Target,2018-07-13 09:16:00-04:00,MEIP,positive
818949.0,"Benzinga's Top Upgrades, Downgrades For July 13, 2018",2018-07-13 09:05:00-04:00,MEIP,positive
818950.0,"SunTrust Robinson Humphrey Initiates Coverage On MEI Pharma with Buy Rating, Announces $12 Price Target",2018-07-13 07:26:00-04:00,MEIP,neutral
818951.0,28 Stocks Moving In Monday's Pre-Market Session,2018-07-02 08:06:00-04:00,MEIP,neutral
818952.0,"MEI Pharma Reports Presentation Of Data On ME-401 At European Hematology Association Congress; Showed 90% Response Rate Across All Patient Groups Treated, Was Generally Well Tolerated",2018-06-15 08:12:00-04:00,MEIP,positive
818953.0,36 Stocks Moving In Thursday's Mid-Day Session,2018-06-07 12:30:00-04:00,MEIP,neutral
818954.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-06-07 08:20:00-04:00,MEIP,neutral
818955.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,MEIP,neutral
818956.0,40 Biggest Movers From Yesterday,2018-06-07 04:50:00-04:00,MEIP,neutral
818957.0,Mid-Afternoon Market Update: Dow Rises Over 200 Points; Ambarella Shares Slide On Weak Sales Forecast,2018-06-06 14:31:00-04:00,MEIP,negative
818958.0,28 Stocks Moving In Wednesday's Mid-Day Session,2018-06-06 12:24:00-04:00,MEIP,neutral
818959.0,MEI Pharma Shares Up 12.8% After Wells Fargo Upgraded To Outperform,2018-06-06 10:03:00-04:00,MEIP,positive
818960.0,"Benzinga's Top Upgrades, Downgrades For June 6, 2018",2018-06-06 09:16:00-04:00,MEIP,positive
818961.0,Wells Fargo Upgrades MEI Pharma to Outperform,2018-06-06 09:12:00-04:00,MEIP,positive
818962.0,"Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate",2018-06-06 08:38:00-04:00,MEIP,positive
818963.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-06-06 08:12:00-04:00,MEIP,neutral
818964.0,45 Biggest Movers From Yesterday,2018-06-06 04:35:00-04:00,MEIP,neutral
818965.0,MEI Pharma Gives an Update on ME-344 Into ASCO,2018-06-04 08:17:00-04:00,MEIP,neutral
818966.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,MEIP,negative
818967.0,UPDATE: MEI Pharma Says 'Predefined Patient Retention Threshold Met: 10% Early Discontinuation Rate Due to Adverse Events Supports Expansion of Patient Enrollment',2018-05-31 08:33:00-04:00,MEIP,neutral
818968.0,"MEI Pharma, Helsinn Group Report Interim Analysis Of Pracinostat/Azacitidine Phase 2 Combo Study In Higher Risk Myelodysplastic Syndrome Patients",2018-05-31 08:33:00-04:00,MEIP,negative
818969.0,"Caxton Corporation Reports 9.1% Passive Stake in MEI Pharma Inc as of May 16, 2018",2018-05-25 06:07:00-04:00,MEIP,positive
818970.0,"Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings",2018-05-16 08:10:00-04:00,MEIP,neutral
818971.0,45 Biggest Movers From Yesterday,2018-05-16 06:01:00-04:00,MEIP,neutral
818972.0,37 Stocks Moving In Tuesday's Mid-Day Session,2018-05-15 12:32:00-04:00,MEIP,neutral
818973.0,48 Biggest Movers From Yesterday,2018-05-15 04:26:00-04:00,MEIP,neutral
818974.0,MEI Pharma Announces $75M Private Placement,2018-05-14 08:00:00-04:00,MEIP,neutral
818975.0,"MEI Pharma Q3 EPS $(0.16) Beats $(0.27) Estimate, Sales $433K Beat $200K Estimate",2018-05-09 08:33:00-04:00,MEIP,neutral
818976.0,18 Stocks Moving In Friday's Pre-Market Session,2018-04-20 08:23:00-04:00,MEIP,neutral
818977.0,41 Biggest Movers From Yesterday,2018-04-13 05:04:00-04:00,MEIP,neutral
818978.0,33 Stocks Moving In Thursday's Mid-Day Session,2018-04-12 12:31:00-04:00,MEIP,neutral
818979.0,"Benzinga's Top Upgrades, Downgrades For April 12, 2018",2018-04-12 09:27:00-04:00,MEIP,positive
818980.0,"Laidlaw & Co. Initiates Coverage On MEI Pharma with Buy Rating, Announces $7.00 Price Target",2018-04-12 07:18:00-04:00,MEIP,neutral
818981.0,MEI Pharma Interim Data Review Supports Continuation of Clinical Study Evaluating ME-344 in Patients with Breast Cancer,2018-02-13 08:11:00-05:00,MEIP,negative
818982.0,MEI Pharma Reports Q2 EPS $(0.16) vs $(0.28) Est.,2018-02-08 08:05:00-05:00,MEIP,neutral
818983.0,46 Biggest Movers From Yesterday,2018-01-12 05:25:00-05:00,MEIP,neutral
818984.0,38 Stocks Moving In Thursday's Mid-Day Session,2018-01-11 13:18:00-05:00,MEIP,neutral
818985.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-01-11 08:37:00-05:00,MEIP,neutral
818986.0,Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML),2018-01-11 06:54:00-05:00,MEIP,neutral
818987.0,MEI Pharma Reports FDA Clearance Of INDA For Voruciclib,2018-01-08 09:26:00-05:00,MEIP,neutral
818988.0,MEI Pharma Reports Study Of Clinical Stage Oral CDK Inhibitor Voruciclib Published In Nature Scientific Reports: 'Studies Demonstrate Repression of MCL-1 and Sensitization to BCL-2 Inhibition in Diffuse Large B-Cell Lymphoma',2017-12-21 09:02:00-05:00,MEIP,negative
818989.0,"MEI Pharma Reports Q1 EPS $(0.24) vs $(0.27) Est., Sales $283K vs $160K",2017-11-08 09:01:00-05:00,MEIP,neutral
818990.0,"BZ NOTE: EC Public Health Doc On Orphan Designation For Pracinostat Is Sponsored By Helsinn Birex Pharma In Ireland; Co., MEI Pharma Announced Strategic Deal For Development Of Drug In 2016",2017-10-19 10:16:00-04:00,MEIP,positive
818991.0,"MEI Pharma Shares Spike ~5% As Traders Circulate EC Public Health Doc Showing Registration For Orphan Medicinal Products For Co.'s AML Treatment, Pracinostat",2017-10-19 10:13:00-04:00,MEIP,positive
818992.0,Buying Stocks Below Their Cash Value,2017-10-10 12:30:00-04:00,MEIP,positive
818993.0,12 Biggest Mid-Day Gainers For Tuesday,2017-09-05 12:35:00-04:00,MEIP,neutral
818994.0,"Earnings Scheduled For September 5, 2017",2017-09-05 05:05:00-04:00,MEIP,neutral
818995.0,"Helsinn Group, MEI Pharma Report First Patient Dosed in Pivotal Phase 3 Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia",2017-08-02 08:07:00-04:00,MEIP,neutral
819006.0,"MEI Pharma, Helsinn Group Report First Patient Dosed In Phase 2 Dose-Optimization Study Of Pracinostat In Combo With Azacitidine In Patients With Higher Risk MDS",2017-06-14 08:36:00-04:00,MEIP,negative
819012.0,"MEI Pharma, Helsinn Report Correlation Between Mutations in DNA Methylation Pathway, Clinical Response in Phase II Study of Pracinostat, Azacitidine in Acute Myeloid Leukemia",2017-06-05 09:01:00-04:00,MEIP,neutral
819013.0,"Oppenheimer Issues Mid-Day Note on MEI Pharma: ME-401 'could be a highly competitive PI3K inhibitor with a preferred safety profile,' Highlights There Have Been No Reports of ALT/AST Elevations, Colitis or Pneumonitis",2017-05-31 11:14:00-04:00,MEIP,positive
819014.0,"MEI Pharma Reports Pre-Specified Response Rate Exceeded in Dose-Escalation Study of ME-401 in Chronic Lymphocytic Leukemia, Follicular Lymphoma",2017-05-31 08:32:00-04:00,MEIP,neutral
819015.0,15 Biggest Mid-Day Gainers For Thursday,2017-05-25 12:28:00-04:00,MEIP,neutral
819016.0,"Benzinga's Top Upgrades, Downgrades For May 25, 2017",2017-05-25 09:35:00-04:00,MEIP,positive
819017.0,"Oppenheimer Initiates Coverage On MEI Pharma with Outperform Rating, Announces $6.50 Price Target",2017-05-25 07:39:00-04:00,MEIP,neutral
819018.0,Stifel's ASCO Abstract Cheat Sheet,2017-05-18 09:57:00-04:00,MEIP,negative
819019.0,"MEI Pharma Reports Q3 EPS $(0.02) vs $(0.04) Est., Sales $4.5M",2017-05-04 09:01:00-04:00,MEIP,neutral
819020.0,MEI Pharma Names Brian Drazba CFO,2017-04-03 08:03:00-04:00,MEIP,neutral
819021.0,"MEI Pharma Reports Q2 EPS $0.32 vs $(0.15) in Same Qtr. Last Year, Sales $17.199M",2017-02-08 08:32:00-05:00,MEIP,neutral
819022.0,"Helsinn Group, MEI Pharma Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia",2016-12-05 08:03:00-05:00,MEIP,neutral
819023.0,"MEI Pharma Reports Q1 EPS $(0.12) vs. Est. $(0.15), Rev. $1.096M vs. Est. $630K",2016-11-09 08:32:00-05:00,MEIP,neutral
819024.0,"MEI Pharma FY EPS ($0.61) vs ($0.65) est, No Revenue",2016-09-06 08:33:00-04:00,MEIP,negative
819025.0,MEI Pharma Reduces Board Size from Eight to Even Members,2016-09-02 10:55:00-04:00,MEIP,neutral
819026.0,MEI Pharma To Reduce Board Size To 7 Directors,2016-09-02 10:55:00-04:00,MEIP,neutral
819027.0,Helsinn Investment Fund Reports 7.1% Stake in MEI Pharma in 13G,2016-08-22 14:49:00-04:00,MEIP,neutral
819028.0,Mid-Afternoon Market Update: Crude Oil Up 3.5%; Ceragon Shares Drop Following Q2 Results,2016-08-08 14:31:00-04:00,MEIP,negative
819029.0,15 Biggest Mid-Day Gainers For Monday,2016-08-08 12:43:00-04:00,MEIP,neutral
819030.0,Mid-Day Market Update: Mattress Firm Jumps Following Buyout; Digital Ally Shares Slide,2016-08-08 12:05:00-04:00,MEIP,positive
819031.0,Stocks Hitting 52-Week Highs,2016-08-08 10:16:00-04:00,MEIP,neutral
819032.0,Mid-Morning Market Update: Markets Edge Lower; Tyson Foods Tops Q3 Expectations,2016-08-08 10:08:00-04:00,MEIP,positive
819033.0,"MEI Pharma Shares Resume Trade, Now Up 41.6% to ~$2.28",2016-08-08 08:31:00-04:00,MEIP,positive
819034.0,11 Stocks Moving In Monday's Pre-Market Session,2016-08-08 08:26:00-04:00,MEIP,neutral
819035.0,MEI Pharma Shares to Resume Trade at 8:30 a.m. EDT,2016-08-08 08:08:00-04:00,MEIP,positive
819036.0,"UPDATE: MEI Pharma Will Receive Near-Term Payments of $20M, Will Be Eligible to Receive Up to $444M in Potential Development",2016-08-08 08:03:00-04:00,MEIP,neutral
819037.0,"Helsinn, MEI Pharma Announce Strategic Deal for Development, Commercialization of Pracinostat for Treatment of AML, Other Hematologic Diseases",2016-08-08 08:03:00-04:00,MEIP,positive
819038.0,MEI Pharma Shares Halted News Pending,2016-08-08 07:55:00-04:00,MEIP,positive
819039.0,MEI Pharma's Pracinostat Gets Breakthrough Therapy Status For Its Pracinostat In Combination With Azacitidine,2016-08-01 09:52:00-04:00,MEIP,neutral
819040.0,MEI Pharma's Pracinostat Receives Breakthrough Therapy Designation from FDA for Treatment in Combination with Azacitidine of Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy,2016-08-01 08:31:00-04:00,MEIP,neutral
819041.0,MEI Pharma Offers New Clinical Data from First-in-Human Study of ME-401,2016-04-20 08:03:00-04:00,MEIP,neutral
819042.0,Vivo Ventrues Reports 7.2% Stake MEI Pharma in 13D,2016-04-07 15:02:00-04:00,MEIP,neutral
819043.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,MEIP,positive
819044.0,Morning Market Gainers,2015-12-07 09:44:00-05:00,MEIP,neutral
819045.0,"MEI Pharma Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study",2015-12-07 08:30:00-05:00,MEIP,positive
819046.0,BZ NOTE: Watch Biotech Stocks As ASH Conference Abstracts To Be Released At 9pm ET,2015-11-05 08:30:00-05:00,MEIP,positive
819047.0,MEI Pharma Announces Data from Phase II Clinical Studies of Pracinostat Accepted for Oral Presentation at American Society of Hematology Annual Meeting,2015-10-06 09:01:00-04:00,MEIP,positive
819048.0,MEI Pharma Updates Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Recently Diagnosed Acute Myeloid Leukemia,2015-06-12 08:02:00-04:00,MEIP,neutral
819049.0,MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies,2015-05-04 09:04:00-04:00,MEIP,negative
819050.0,Cantor Is Slashing Its MEI Pharma Price Target,2015-03-24 17:12:00-04:00,MEIP,negative
819051.0,Wells Fargo Downgrades MEI Pharma To  Market Perform,2015-03-24 09:26:00-04:00,MEIP,positive
819052.0,Benzinga's Top Downgrades,2015-03-24 08:36:00-04:00,MEIP,positive
819053.0,Wells Fargo Downgrades MEI Pharma to Market Perform,2015-03-24 06:04:00-04:00,MEIP,positive
819054.0,"Wedbush Downgrades MEI Pharma to Neutral, Lowers PT to $3.00",2015-03-23 12:39:00-04:00,MEIP,negative
819055.0,ICYMI: Pharmaceutical Stocks Are Moving Big On Monday,2015-03-23 12:13:00-04:00,MEIP,neutral
819056.0,Morning Market Losers,2015-03-23 10:02:00-04:00,MEIP,negative
819057.0,Roth Capital Downgrades MEI Pharma to Neutral,2015-03-23 09:17:00-04:00,MEIP,neutral
819058.0,Benzinga's Top #PreMarket Losers,2015-03-23 08:15:00-04:00,MEIP,negative
819059.0,"UPDATE: MEI Pharma Shares Fall 60% Premarket on Failed Pracinostat,Azacitidine Phase II Study",2015-03-23 07:44:00-04:00,MEIP,negative
819060.0,"Mei Pharma Says Combination of Pracinostat, Azacitidine Showed No Difference in Rate of Complete Remission Compared to Azacitidine Alone",2015-03-23 07:10:00-04:00,MEIP,negative
819061.0,Mid-Morning Market Update: Markets Open Lower; Deere Lowers FY15 Forecast,2015-02-20 10:47:00-05:00,MEIP,negative
819062.0,"Top Performing Industries For February 20, 2015",2015-02-20 10:31:00-05:00,MEIP,positive
819063.0,"Bank of America Initiates Coverage on MEI Pharma at Buy, Announces $9.00 PT",2015-02-20 06:35:00-05:00,MEIP,neutral
819064.0,Benzinga's Top Initiations,2015-02-06 09:15:00-05:00,MEIP,positive
819065.0,Wells Fargo Initiates MEI Pharma With Outperform,2015-02-06 08:45:00-05:00,MEIP,positive
819066.0,Wells Fargo Initiates Coverage on MEI Pharma at Outperform,2015-02-06 06:23:00-05:00,MEIP,positive
819067.0,MEI Pharma Announces Achieving of Milestone in Phase II Trial of Pracinostat in Refractory Myelodysplastic Syndrome,2014-12-22 09:01:00-05:00,MEIP,neutral
819068.0,MEI Pharma Prices 10M Common Shares at $4 Apiece,2014-12-12 08:02:00-05:00,MEIP,positive
819069.0,Mid-Day Market Update: Dow Jumps Over 200 Points; Staples Shares Surge On Confirmation Of Stake By Starboard Value,2014-12-11 12:40:00-05:00,MEIP,positive
819070.0,Stocks Hitting 52-Week Lows,2014-12-11 10:23:00-05:00,MEIP,negative
819071.0,MEI Pharma Announces $45M Proposed Public Offering Of Common Stock,2014-12-10 16:02:00-05:00,MEIP,neutral
819072.0,UPDATE: MEI Pharma Reports 45% of Patients to Date Achieved Primary Endpoint,2014-12-08 08:33:00-05:00,MEIP,neutral
819073.0,MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat,2014-12-08 08:32:00-05:00,MEIP,positive
819074.0,MEI Pharma Completes Enrollment In Phase II Study Of Pracinostat,2014-12-02 08:39:00-05:00,MEIP,neutral
819075.0,"Events for the Week of Nov. 17-21, 2014",2014-11-17 13:13:00-05:00,MEIP,neutral
819076.0,MEI Pharma Reports Improved Response Rates in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia ,2014-11-06 09:14:00-05:00,MEIP,positive
819077.0,MEI Pharama Reports Improved Response Rates In Phase II Study of Pracinostat In Front Line Acute Myeloid Leukemia,2014-11-06 09:04:00-05:00,MEIP,positive
819078.0,"MEI Pharma Says First Patient Dosed in Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung, Ovarian Cancers ",2014-10-29 08:34:00-04:00,MEIP,negative
819079.0,MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers ,2014-10-29 08:34:00-04:00,MEIP,negative
819080.0,"Roth Capital Maintains Buy on MEI Pharma, Inc., Raises PT to $22.00",2014-10-16 05:45:00-04:00,MEIP,neutral
819081.0,"Cantor Initiates Coverage on Six Pharma Stocks, Each with Buy",2014-09-08 17:36:00-04:00,MEIP,neutral
819082.0,MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome,2014-09-02 08:33:00-04:00,MEIP,neutral
819083.0,"Mid-Afternoon Market Update; RadioShack Misses More Than Expected, BE Aerospace To Split Into Two Companies",2014-06-10 15:11:00-04:00,MEIP,negative
819084.0,Mid-Day Market Update: Francesca's Falls On Downbeat Results; Achillion Shares Jump,2014-06-10 12:55:00-04:00,MEIP,positive
819085.0,"Top Performing Industries For June 10, 2014",2014-06-10 10:26:00-04:00,MEIP,positive
819086.0,Mid-Morning Market Update: Markets Open Lower; RadioShack Reports Wider Loss,2014-06-10 10:16:00-04:00,MEIP,negative
819087.0,Morning Market Movers ,2014-06-10 09:39:00-04:00,MEIP,neutral
819088.0,Mei Pharma Announces High Response Rates For Phase II Pracinostat Study,2014-06-10 08:31:00-04:00,MEIP,neutral
819089.0,Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength,2014-04-08 15:46:00-04:00,MEIP,positive
819090.0,Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast,2014-04-08 13:22:00-04:00,MEIP,positive
819091.0,Mei Pharma Files for Up to $150M Mixed Shelf,2014-04-08 12:44:00-04:00,MEIP,neutral
819092.0,Benzinga's Volume Movers,2014-03-28 10:34:00-04:00,MEIP,neutral
819093.0,"MEI Pharma, Inc. Reports Q1 EPS of $(0.32) vs $(0.24) Est",2014-02-11 17:03:00-05:00,MEIP,neutral
819094.0,UPDATE: Wedbush Initiates Coverage on MEI Pharma as Best-in-Class Pracinostat Should Shine,2013-12-05 09:44:00-05:00,MEIP,neutral
819095.0,"Wedbush Initiates Coverage on MEI Pharma, Inc. at Outperform, Announces $12.00 PT",2013-12-05 07:30:00-05:00,MEIP,neutral
819096.0,"13G Filing from James Flynn on MEI Pharma Shows 6.38% Stake, Had Shown 3.83% Stake as of Jun. 30th",2013-10-30 12:23:00-04:00,MEIP,neutral
819097.0,MEI Pharma Prices 4.38M Shares at $8/Share,2013-10-25 08:46:00-04:00,MEIP,positive
819098.0,"Stifel Nicolaus Maintains Buy on MEI Pharma, Inc., Raises PT to $15.00",2013-10-22 08:29:00-04:00,MEIP,neutral
819099.0,MEI Pharma Spokesperson Says Strength Today May be Attributed in Part to Astex Acquisition and Also October 19 Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics,2013-09-30 13:23:00-04:00,MEIP,negative
819100.0,"MEI Pharma Begins Phase II Trial of Pracinostat, Vidaza in Frontline Myelodysplastic Syndrome",2013-06-18 08:35:00-04:00,MEIP,neutral
819101.0,"Cowen & Company Initiates Coverage on MEI Pharma, Inc. at Outperform",2013-05-24 08:58:00-04:00,MEIP,neutral
819102.0,"Stifel Nicolaus Initiates Coverage on MEI Pharma, Inc. at Buy, Announces $11.00 PT",2013-04-15 08:39:00-04:00,MEIP,neutral
819103.0,"Stifel Nicolaus Initiates Coverage on MEI Pharma, Inc. at Buy, Announces $11.00 PT",2013-04-15 08:26:00-04:00,MEIP,neutral
819104.0,MEI Pharma's Mitochondrial Inhibitor Drug Candidate ME-344 Delays Tumor Growth In Recurrent Ovarian Cancer Model,2013-04-10 16:01:00-04:00,MEIP,negative
819105.0,MEI Pharma to Offer 2.03M Shares at $7.50/Share,2013-04-05 07:33:00-04:00,MEIP,positive
819106.0,MEI Pharma Announces Closing Of $27.5M Private Placement,2012-12-19 08:32:00-05:00,MEIP,neutral
819107.0,Morning Market Losers,2012-12-11 10:00:00-05:00,MEIP,negative
819108.0,Morning Market Losers,2012-11-26 09:56:00-05:00,MEIP,negative
819109.0,MEI Pharma Announces $27.5 Million Private Placement,2012-11-05 08:37:00-05:00,MEIP,neutral
819110.0,MEI Pharma to Acquire Pracinostat,2012-08-08 09:07:00-04:00,MEIP,neutral
